ZEB2 and hepatocellular carcinoma: The increased expression and the oncogenic function of ZEB2‐AS1 were confirmed in several cancers, including hepatocellular carcinoma,21 bladder cancer,9 pancreatic cancer,22 colorectal cancer,23 and triple‐negative breast cancer.11